The potential of physicochemical and immunochemical assays to replace animal tests in the quality control of toxoid vaccines: The report and recommendations of ECVAM workshop 61a

ATLA Alternatives to Laboratory Animals

Volumn 35, Issue 3, 2007, Pages 323-331

  Metz, Bernard ^a   Brunel, Florence ^b   Chamberlin, Catherine ^c   Van Der Gun, Johan ^a   Halder, Marlies ^d   Jiskoot, Wim ^e   Kersten, Gideon ^a   Van Opstal, Orner ^f   Petersen, Jesper W ^g   Ravetkar, Satish D ^h   Redhead, Keith ⁱ   Schwanig, Michael ^j   Wiiheimsen, Ellen Sloth ^g   Vann, Willie F ^k   Hendriksen, Coenraad ^a,d,l  

^a NETHERLANDS VACCINE INSTITUTE   (Netherlands)

^b SANOFI PASTEUR   (France)

^c European Network of National Information Centers   (France)

^d JOINT RESEARCH CENTRE   (Italy)

^e LEIDEN UNIVERSITY   (Netherlands)

^f GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^g STATENS SERUM INSTITUT   (Denmark)

^h Serum Institute of India Ltd   (India)

ⁱ Walton Manor   (United Kingdom)

^j PAUL EHRLICH INSTITUT   (Germany)

^k CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^l UTRECHT UNIVERSITY   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA ANTIBODY; TETANUS TOXOID;

DIPHTHERIA; DRUG SAFETY; EXPERIMENTAL ANIMAL; IMMUNOCHEMISTRY; INFECTION PREVENTION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; TETANUS;

ANIMALIA;

EID: 34547774664     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290703500307     Document Type: Review

References (31)

1. Anon. (1994). ECVAM News & Views. ATLA 22, 7-11.
2. Metz, B., Hendriksen, C., Jiskoot, W. & Kersten, G. (2002). Reduction of animal use in human vaccine quality control: opportunities and problems. Vaccine 20, 2411-2430.
3. McCullough, K., Hendriksen, C. & Seebeck, T. (1997). In vitro methods in vaccinology. In Veterinary Vaccinology (ed. P. Pastoret, J. Blancou, P. Vannier & C. Verschueren), pp. 69-112. Amsterdam, The Netherlands: Elsevier Science.
4. Zoon, K. & Garnick, R. (1998). Definition of a well-characterized biotechnology product. Developments in Biological Standardization 96, 191-197.
5. World Health Organization (2005). Recommendations for Diphtheria, Tetanus, Pertussis and Combined Vaccines. WHO Technical Report Series, No. 927, Annex 5: (Amendments 2003), 10pp. Geneva, Switzerland: World Health Organization. Website http://www.who.int/biologicals/publications/trs/areas/ vaccines/dtp/ANNEX%205%20DTPP138-147.pdf (Accessed 28.02.07).
6. Chirino, A.J. & Mire-Sluis, A. (2004). Characterizing biological products and assessing comparability following manufacturing changes. Nature Biotechnology 22, 1383-1391.
7. Glenny, A.T. & Hopkins, B.E. (1923). Diphtheria toxoid as an immunising agent. British Journal of Experimental Pathology 4, 283-287.
8. Ramon, G. (1924). Sur la toxine et sur l'anatoxine diphtériques. Annales de l'Institut Pasteur 38, 1-10.
9. Metz, B., Kersten, G.F.A, Hoogerhout, P., Brugghe, H.F., Timmermans, H.A., de Jong, A., Meiring, H., ten Hove, J., Hennink, W.E., Crommelin, D.J. & Jiskoot, W. (2004). Identification of formaldehyde-induced modifications in proteins: reactions with model peptides. Journal of Biological Chemistry 279, 6235-6243.
10. Theeten, H., Van Damme, P., Hoppenbrouwers, K., Vandermeulen, C., Leback, E., Sokal, E.M., Wolter, J. & Schuerman, L. (2005). Effects of lowering the aluminium content of a dTpa vaccine on its immunogenicity and reactogenicity when given as a booster to adolescents. Vaccine 23, 1515-1521.
11. Gupta, R.K. & Siber, G.R. (1995). Adjuvants for human vaccines - current status, problems and future prospects. Vaccine 13, 1263-1276.
12. Gupta, R.K. (1998). Aluminum compounds as vaccine adjuvants. Advanced Drug Delivery Reviews 32, 155-172.
13. Jones, L.S., Peek, L.J., Power, J., Markham, A., Yazzie, B. & Middaugh, C.R. (2005). Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens. Journal of Biological Chemistry 280, 13,406-13,414.
14. Capelle, M.A., Brugger, P. & Arvinte, T. (2005). Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity. Vaccine 23, 1686-1694.
15. Council of Europe (2007). 2.7.8. Assay of tetanus vaccine (absorbed). In: European Pharmacopoeia, 5th Edition, Supplement 5.7, pp. 4793-4798. Strasbourg, France: Council of Europe.
16. Council of Europe (2007). 2.7.6. Assay of diphtheria vaccine (adsorbed). In: European Pharmacopoeia, 5th Edition, Supplement 5.7, pp. 4789-4793. Strasbourg, France: Council of Europe.
17. Knutsson, N., Trollfors, B., Taranger, J., Bergfors, E., Sundh, V., Lagergard, T., Ostergaard, E., Cicirello, H. & Kayhty, H. (2001). Immunogenicity and reactogenicity of diphtheria, tetanus and pertussis toxoids combined with inactivated polio vaccine, when administered concomitantly with or as a diluent for a Hib conjugate vaccine. Vaccine 19, 4396-4403.
18. Di Tommaso, A., de Magistris, M.T., Bugnoli, M., Marsili, I., Rappuoli, R. & Abrignani, S. (1994). Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen processing. Infection and Immunity 62, 1830-1834.
19. Metz, B., Jiskoot, W., Hennink, W.E., Crommelin, D.J.A. & Kersten, G.F.A. (2003). Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines. Vaccine 22, 156-167.
20. Council of Europe (2005). Diphtheria vaccine (adsorbed). In: European Pharmacopoeia, 5th Edition, pp. 660-661. Strasbourg, France: Council of Europe.
21. Council of Europe (2005). Tetanus vaccine (adsorbed). In: European Pharmacopoeia, 5th Edition, pp. 702-703. Strasbourg, France: Council of Europe.
22. Kegel, B., Bonifas, U., Silberbach, K., Kramer, B. & Weisser, K. (2002). In vitro determination of specific toxicity in tetanus vaccines. In Advancing Science and Elimination of the Use of Laboratory Animals for Development and control of Vaccines and Hormones (ed. F. Brown, C. Hendriksen, D. Sesardic & K. Cussler). Developments in Biologicals 111, 27-33. Basel, Switzerland: S. Karger AG.
23. Sesardic, D. (2002). Alternatives in testing of bacterial toxins and antitoxins. In Advancing Science and Elimination of the Use of Laboratory Animals for Development and control of Vaccines and Hormones (ed. F. Brown, C. Hendriksen, D. Sesardic & K. Cussler). Developments in Biologicals 111, 101-108. Basel, Switzerland: S. Karger AG.
24. Cyr, T., Menzies, A.J., Calver, J. & Whitehouse, L.W. (2001). A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products. Biologicals 29, 81-95.
25. Frech, C., Hubert, A.K., Hartmann, G., Mayer, K., Sauer, T. & Bolgiano, B. (2000). Physicochemical analysis of purified diphtheria toxoids: is toxoided then purified the same as purified then toxoided? In: Physico-Chemical Procedures for the Characterization of Vaccines (ed. F. Brown, M.J. Corbel & E. Griffiths). Developments in Biologicals 103, 202-215. Basel, Switzerland: S. Karger AG.
26. Paliwal, R. & London, E. (1996). Comparison of the conformation, hydrophobicity, and model membrane interactions of diphtheria toxin to those of formaldehyde-treated toxin (diphtheria toxoid): formaldehyde stabilization of the native conformation inhibits changes that allow membrane insertion. Biochemistry 35, 2374-2379.
27. Aggerbeck, H. & Heron, I. (1992). Detoxification of diphtheria and tetanus toxin with formaldehyde. Detection of protein conjugates. Biologicals 20, 109-115.
28. Doshi, J.B., Ravetkar, S.D., Ghole, V.S. & Rehani, K. (2003). Comparative quantitation for the protein content of diphtheria and tetanus toxoids by DC protein assay and Kjeldahl method. Biologicals 31, 187-189.
29. Bolgiano, B., Fowler, S., Turner, K., Sesardic, D., Xing, D.K., Crane, D.T. & Corbel, M.J. (2000). Monitoring of diphtheria, pertussis and tetanus toxoids by circular dichroism, fluorescence spectroscopy and size-exclusion chromatography. In Physico-Chemical Procedures for the Characterization of Vaccines (ed. F. Brown, M.J. Corbel & E. Griffiths). Developments in Biologicals 103, 51-59. Basel, Switzerland: S. Karger AG.
30. Chang, M., Shi, Y., Nail, S.L., HogenEsch H., Adams, S.B., White, J.L. & Hem, S.L. (2001). Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits. Vaccine 19, 2884-2889.
31. Wittayanukulluk, A., Jiang, D., Regnier, F.E. & Hem, S.L. (2004). Effect of microenvironment pH of aluminum hydroxide adjuvant on the chemical stability of adsorbed antigen. Vaccine 22, 1172-1176.